| 2015 | De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer | GYNECOLOGIC ONCOLOGY |
| 2017 | Delayed hemorrhage effect of local anesthesia with epinephrine in the loop electrosurgical excisional procedure
| Obstetrics & Gynecology Science |
| 2018 | Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2
| CANCER RESEARCH AND TREATMENT |
| 2010 | Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI | GYNECOLOGIC ONCOLOGY |
| 2017 | Diagnostic and clinicopathological significance of Ki67 mRNA expression in cervical cancer tissue
| INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY |
| 2018 | Diagnostic Value of 18F-FDG PET/CT and MRI in the Preoperative Evaluation of Uterine Carcinosarcoma | NUCLEAR MEDICINE AND MOLECULAR IMAGING |
| 2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
| 2018 | Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5' and 3' Exons | Anticancer Research |
| 2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
| CANCERS |
| 2017 | Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas
| ONCOTARGET |
| 2020 | Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
| CANCER RESEARCH AND TREATMENT |
| 2020 | Effect of bupivacaine versus lidocaine local anesthesia on postoperative pain reduction in single-port access laparoscopic adnexal surgery using propensity score matching
| Obstetrics & Gynecology Science |
| 2007 | Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy | GYNECOLOGIC ONCOLOGY |
| 2021 | Effects of Korean Red Ginseng ( Panax ginseng C.A. Meyer) on Menopausal Symptoms in Premenopausal Women After Gynecologic Cancer Surgery: A Double-Blind, Randomized Controlled Trial | JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE |
| 2013 | Effects of Uterine Manipulation on Surgical Outcomes in Laparoscopic Management of Endometrial Cancer: A Prospective Randomized Clinical Trial | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2010 | Efficacy and toxicity of belotecan with and without cisplatin in patients with recurrent ovarian cancer | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2019 | Elevated serum interleukin-32 levels in patients with endometriosis: A cross-sectional study | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY |
| 2008 | Endometrial stromal sarcomas: a retrospective analysis of 28 patients, single center experience for 20 years
| CANCER RESEARCH AND TREATMENT |
| 2018 | Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.
| PLOS ONE |
| 2002 | Expression of E-Cadherin and α-, β-, γ-Catenin Proteins in Endometrial Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2007 | Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma | INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS |
| 2009 | Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma
| Clinical and Vaccine Immunology |
| 2018 | Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer | GYNECOLOGIC ONCOLOGY |
| 2014 | Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer | GENES CHROMOSOMES & CANCER |
| 2008 | Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection.
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | Expression profiles of id and E2A in ovarian cancer and sup-pression of ovarian cancer by the E2A isoform E47 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47
| CANCERS |
| 2006 | Expression profiling of cyclin B1 and D1 in cervical carcinoma | EXPERIMENTAL ONCOLOGY |
| 2017 | External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer
| FRONTIERS IN ONCOLOGY |
| 2011 | Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer. | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2013 | FGF18 as a prognostic and therapeutic biomarker in ovarian cancer
| JOURNAL OF CLINICAL INVESTIGATION |
| 2023 | Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer | BRITISH JOURNAL OF CANCER |
| 2016 | Genetic analysis of ovarian microcystic stromal tumor
| Obstetrics & Gynecology Science |
| 2021 | Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix | MODERN PATHOLOGY |
| 2019 | Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer
| Cancer Research and Treatment |
| 2008 | Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line. | MOLECULAR AND CELLULAR BIOCHEMISTRY |
| 2020 | Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
| BMC CANCER |
| 2005 | Germline Mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma | GYNECOLOGIC ONCOLOGY |
| 2004 | Granulocytic sarcoma of the uterine cervix | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | High mobility group box-1 promotes inflammation in endometriotic stromal cells through Toll-like receptor 4/nuclear factor-kappa B
| AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH |
| 2012 | High-dose-rate intracavitary radiotherapy in the management of cervical intraepithelial neoplasia 3 and carcinoma in situ presenting with poor histologic factors after undergoing excisional procedures. | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2019 | How to use immune checkpoint inhibitor in ovarian cancer?
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2014 | HPV Vaccine, Is It Really Harmful?
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2012 | Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study | EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY |
| 2022 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTS | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2023 | Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy | JAMA SURGERY |
| 2017 | Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy.
| YONSEI MEDICAL JOURNAL |
| 2014 | Identification of Novel Epitopes From Human Papillomavirus Type 18 E7 That Can Sensitize PBMCs of Multiple HLA class I Against Human Cervical Cancer
| JOURNAL OF TRANSLATIONAL MEDICINE |
| 2022 | IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component | MODERN PATHOLOGY |
| 2018 | Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center.
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2021 | Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | Impact of the Learning Curve on the Survival of Abdominal or Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
| CANCER RESEARCH AND TREATMENT |
| 2018 | Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer. | GYNECOLOGIC ONCOLOGY |
| 2018 | In-bag power morcellation technique in single-port laparoscopic myomectomy
| Obstetrics & Gynecology Science |
| 2022 | Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study | GYNECOLOGIC ONCOLOGY |
| 2019 | Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
